Efficacy and Safety of Trastuzumab Combined with Pertuzumab for Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer: A Meta-Analysis Study of Randomized Control Trials

Figure 2

The risk of bias for the included study. (a) Risk of bias summary. (b) Risk of bias graph.

(a)

(b)